Doctronic logo spinning
Skipping wait room
AI Doctor ready
Starting secure consult

Preventing Complications in MS: The Power of Monitoring

Published: Aug 30, 2024

For multiple sclerosis patients, regular monitoring can prevent severe complications and ensure effective treatment. Discover how monitoring plays a vital role in MS management.
Contents

The Importance of Regular Screening

Regular screening is critical in identifying potential risks and complications early, such as infections or treatment-related side effects. For MS patients on therapies like natalizumab, monitoring for JC virus antibodies can prevent the development of PML, a serious brain infection. Regular screenings allow for timely interventions and adjustments to treatment plans.

Monitoring Treatment Efficacy

Monitoring helps assess how well treatments are working by tracking disease activity and progression through MRI scans and clinical evaluations. Adjustments to medication or dosing can be made based on these findings, ensuring patients receive the most effective care. This proactive approach helps maintain disease control and improve quality of life.
Regular monitoring and screenings are vital in managing multiple sclerosis to prevent complications such as PML and assess treatment efficacy.

Managing Side Effects

Regular monitoring also involves checking for side effects such as liver issues or infusion reactions. Early detection of side effects allows for prompt management, reducing the risk of complications. Patients should report any new symptoms to their healthcare provider to ensure swift action is taken.

Frequently Asked Questions

It helps identify risks and prevent complications early.

Through MRI scans and clinical evaluations.

Any new symptoms or side effects to their healthcare provider.

It ensures timely treatment adjustments for better disease control.

Get Started

Monitoring is crucial in managing MS effectively and preventing complications.
Schedule a discussion with Doctronic to explore comprehensive monitoring strategies for your MS management.

Related Articles

References

  1. StΓΌve O, Marra CM, Jerome KR, et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol 2006; 59:743.
  2. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 2012; 366:1870.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

πŸ˜€ πŸ˜€ πŸ˜€
sthetoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely